Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.4 - $1.95 $2.3 Million - $3.21 Million
1,645,206 Added 548.4%
1,945,206 $3.52 Million
Q1 2023

May 15, 2023

BUY
$1.21 - $2.22 $322,164 - $591,079
266,252 Added 788.94%
300,000 $396,000
Q4 2022

Feb 14, 2023

SELL
$0.85 - $1.69 $86,882 - $172,743
-102,215 Reduced 75.18%
33,748 $57,000
Q2 2022

Aug 15, 2022

BUY
$2.84 - $8.57 $386,134 - $1.17 Million
135,963 New
135,963 $417,000

Others Institutions Holding PRDS

About PARDES BIOSCIENCES, INC.


  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.